Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Leases (2023 - 2026)

Camp4 Therapeutics' Current Leases history spans 3 years, with the latest figure at $286000.0 for Q4 2025.

  • On a quarterly basis, Current Leases fell 90.45% to $286000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $286000.0, a 90.45% decrease, with the full-year FY2025 number at $286000.0, down 90.45% from a year prior.
  • Current Leases hit $286000.0 in Q4 2025 for Camp4 Therapeutics, up from $27000.0 in the prior quarter.
  • Over the last five years, Current Leases for CAMP hit a ceiling of $3.1 million in Q2 2025 and a floor of $27000.0 in Q3 2025.
  • Historically, Current Leases has averaged $1.0 million across 3 years, with a median of $286000.0 in 2025.
  • Biggest five-year swings in Current Leases: skyrocketed 745.76% in 2024 and later crashed 90.45% in 2025.
  • Tracing CAMP's Current Leases over 3 years: stood at $354000.0 in 2023, then skyrocketed by 745.76% to $3.0 million in 2024, then tumbled by 90.45% to $286000.0 in 2025.
  • Business Quant data shows Current Leases for CAMP at $286000.0 in Q4 2025, $27000.0 in Q3 2025, and $3.1 million in Q2 2025.